Experience

Tosoh Bioscience - Separations & Purification

• Japan
• Biotechnology
• 100 - 200 Employee

• Regulatory Support Manager

  • Aug 2021 - Present



Eurofins BioPharma Product Testing (US)

• United States
• Biotechnology Research
• 100 - 200 Employee

• Group Leader III

  • Oct 2019 - Aug 2021

  I manage a core group of six scientists leading viral clearance studies while maintaining a full laboratory schedule. My laboratory responsibilities included performing a wide range of analyses (routine and non-routine) primarily, but not limited to, cell biology and virology test areas for Biopharmaceutical Services; reviewing and evaluating raw data for acceptability; setting up and validating new analytical or related processes used by the department; documenting work as required for cGMP compliance.



ACT Lab

• United States
• Biotechnology Research
• 1 - 100 Employee

• Eastern Laboratory Director

  • May 2019 - Oct 2019



Eurofins Lancaster Laboratories

• United States
• Biotechnology Research
• 700 & Above Employee

• Senior Scientist

  • Nov 2015 - May 2019

  My responsibilities included performing a wide range of analyses (routine and non-routine) primarily, but not limited to, cell biology and virology test areas for Biopharmaceutical Services; reviewing and evaluating raw data for acceptability; setting up and validating new analytical or related processes used by the department; documenting work as required for cGMP compliance. My responsibilities included performing a wide range of analyses (routine and non-routine) primarily, but not limited to, cell biology and virology test areas for Biopharmaceutical Services; reviewing and evaluating raw data for acceptability; setting up and validating new analytical or related processes used by the department; documenting work as required for cGMP compliance.



GSK

• United Kingdom
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Intern Scientist

  • Sep 2012 - Jul 2013

  • Operated robotic micro dilution machinery, and tested susceptibility of key pathogenic bacteria to novel small molecule candidates • Investigated occurrence of resistance to novel antibacterial leads and analyzed cell killing activity of new molecules • Investigated genes of interest in studying resistance patterns of bacterial targets • Prepared bacterial growth media • Sub-cultured frozen isolates and create frozen glycerol stocks • Ordered, retrieved, and organized lab supplies to facilitate high output screening • Efficiently analyzed, studied, and provided results and conclusions to manager for team presentation • Trained new junior colleagues in the department’s SOPs to maintain efficiency and high quality results